IL5 and congenital rubella syndrome: The specific knowledge on the role of IL5 in CRS with NP as discovered previously [66] and the possibility of IL5 antagonism in vitro[67] led to the clinical application of humanized anti-IL5 antibodies for the treatment of nasal polyposis [68], [69].